Bioneer (A064550) Stock Overview
Operates as a biotechnology company in South Korea, the Americas, Europe, Asia, Africa, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
A064550 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Bioneer Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩12,150.00 |
| 52 Week High | ₩19,320.00 |
| 52 Week Low | ₩11,750.00 |
| Beta | 0.095 |
| 1 Month Change | -8.92% |
| 3 Month Change | -7.11% |
| 1 Year Change | -35.85% |
| 3 Year Change | -55.25% |
| 5 Year Change | -37.53% |
| Change since IPO | -12.59% |
Recent News & Updates
Bioneer (KOSDAQ:064550) Is Making Moderate Use Of Debt
Oct 31
Bioneer (KOSDAQ:064550) Is Making Moderate Use Of Debt
Jul 22Is Bioneer (KOSDAQ:064550) Weighed On By Its Debt Load?
Apr 15Bioneer Corporation (KOSDAQ:064550) Not Doing Enough For Some Investors As Its Shares Slump 25%
Mar 04Recent updates
Bioneer (KOSDAQ:064550) Is Making Moderate Use Of Debt
Oct 31Bioneer (KOSDAQ:064550) Is Making Moderate Use Of Debt
Jul 22Is Bioneer (KOSDAQ:064550) Weighed On By Its Debt Load?
Apr 15Bioneer Corporation (KOSDAQ:064550) Not Doing Enough For Some Investors As Its Shares Slump 25%
Mar 04Investors Don't See Light At End Of Bioneer Corporation's (KOSDAQ:064550) Tunnel And Push Stock Down 26%
Nov 14Bioneer Corporation's (KOSDAQ:064550) 27% Dip In Price Shows Sentiment Is Matching Revenues
Sep 06Bioneer Corporation's (KOSDAQ:064550) Share Price Boosted 25% But Its Business Prospects Need A Lift Too
Jul 11Lacklustre Performance Is Driving Bioneer Corporation's (KOSDAQ:064550) Low P/S
Mar 06Bioneer (KOSDAQ:064550) Seems To Use Debt Quite Sensibly
Mar 25Bioneer Corporation's (KOSDAQ:064550) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 15Investors Who Bought Bioneer (KOSDAQ:064550) Shares A Year Ago Are Now Up 166%
Jan 20
Is Bioneer (KOSDAQ:064550) A Risky Investment?
Dec 24Here's Why We Think Bioneer's (KOSDAQ:064550) Statutory Earnings Might Be Conservative
Nov 28Shareholder Returns
| A064550 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | -3.6% | -4.2% | 5.1% |
| 1Y | -35.9% | 52.0% | 84.5% |
Return vs Industry: A064550 underperformed the KR Biotechs industry which returned 47% over the past year.
Return vs Market: A064550 underperformed the KR Market which returned 82.4% over the past year.
Price Volatility
| A064550 volatility | |
|---|---|
| A064550 Average Weekly Movement | 6.5% |
| Biotechs Industry Average Movement | 8.9% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A064550 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A064550's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 367 | Han-Oh Park | www.bioneer.co.kr |
Bioneer Corporation operates as a biotechnology company in South Korea, the Americas, Europe, Asia, Africa, and internationally. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer and solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide function, and magnetic separation services, as well as instruments for conventional PCR, real-time PCR, sample preparation, protein synthesis, centrifuge and vortex mixer, and electrophoresis. It also provides molecular diagnosis, including MDx technologies, human diagnostics kits, MDx extraction kits, and instruments; and products for animal, aquatic-bio, mosquito-borne, and plant diseases, as well as food safety, human pathogen, and nano-bio products.
Bioneer Corporation Fundamentals Summary
| A064550 fundamental statistics | |
|---|---|
| Market cap | ₩313.60b |
| Earnings (TTM) | -₩8.97b |
| Revenue (TTM) | ₩320.69b |
Is A064550 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A064550 income statement (TTM) | |
|---|---|
| Revenue | ₩320.69b |
| Cost of Revenue | ₩73.21b |
| Gross Profit | ₩247.48b |
| Other Expenses | ₩256.45b |
| Earnings | -₩8.97b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -347.63 |
| Gross Margin | 77.17% |
| Net Profit Margin | -2.80% |
| Debt/Equity Ratio | 45.6% |
How did A064550 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/16 17:31 |
| End of Day Share Price | 2026/01/16 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bioneer Corporation is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jiwoo Baek | Shinhan Investment Corp. |
| Choongwoo Seo | SK Securities Co., Ltd. |
| Mihwa Seo | Yuanta Securities Korea Co., Ltd. |